Jordan Olson, MD, FCAP, explains the value of in-house genomic testing. "We've had several instances of patients with aggressive forms of cancer," states Dr. Olson. "In those cases, every moment matters. By testing in-house, our partner physicians got information that gave them a head start on creating personalized treatment plans."
For the full article click here: The value of in-house genomic testing. Lessons learned and operational + patient 'wins' from HNL Lab Medicine and Lehigh Valley Health Network